Irina V. Grebeneva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Irina V. Grebeneva has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Natalia Anatolievna Geppe
Sechenov First Moscow State Medical University (Sechenov University)
6 shared publications - Natalia G. Kolosova
Sechenov First Moscow State Medical University (Sechenov University)
5 shared publications - Veronika D. Denisova
Sechenov First Moscow State Medical University (Sechenov University); Research Clinical Institute of Childhood
5 shared publications - Anita R. Denisova
Sechenov First Moscow State Medical University (Sechenov University)
3 shared publications - A. Yu. Sedova
Sechenov First Moscow State Medical University (Sechenov University)
2 shared publications - Elizaveta V. Aseeva
Sechenov First Moscow State Medical University (Sechenov University); Moscow, Russian Federation
2 shared publications
Latest Publications
- Open Access
- 8 June 2024
- Published by Consilium Medicum in Pediatrics. Consilium Medicum
- No. 1,p. 49-54
Study of the acoustic breathing pattern in children with bronchial asthma using a Respiratory Sound Recorder
Background. The study of external respiration function using spirometry in young children is associated with certain difficulties during the procedure. The respiratory sound recorder is a modern device with which you can evaluate the acoustic breathing pattern during inhalation and exhalation during quiet breathing. Aim. To conduct a comparative analysis of computer bronchophonography indicators in children with asthma and in children in the control group without respiratory pathology using a respiratory sound recorder. Materials and methods. External respiration function was assessed using computer bronchophonography using a respiratory sound recorder; 215 practically healthy children from 1 to 18 years old, who formed the control group, were examined. The main group of those examined included children with moderate (n=80) and severe bronchial asthma (n=40), of which (n=54) patients were examined in exacerbation. Results. In all patients with asthma in the main group with exacerbation, the acoustic component of work of breathing (ACWP) was significantly higher than in the control group. Differences were detected in the low-frequency P1, mid-frequency P2 and high-frequency range P3 (p0.05). When comparing ACRD in patients with asthma with exacerbation and remission, a statistically significant difference was revealed in all frequency ranges (p0.005). When analyzing the duration of inhalation and exhalation in healthy children of different ages, no statistically significant difference was revealed. In patients with exacerbated asthma, inhalation and exhalation were significantly longer than in a healthy child (p0.005). Conclusion. Our study shows that a respiratory sound recorder can be effectively used to diagnose bronchial obstruction disorders in children of different ages.
- 8 June 2024
- Published by Consilium Medicum in Pediatrics. Consilium Medicum
- No. 1,p. 49-54
Open AccessStudy of the acoustic breathing pattern in children with bronchial asthma using a Respiratory Sound Recorder
Background. The study of external respiration function using spirometry in young children is associated with certain difficulties during the procedure. The respiratory sound recorder is a modern device with which you can evaluate the acoustic breathing pattern during inhalation and exhalation during quiet breathing. Aim. To conduct a comparative analysis of computer bronchophonography indicators in children with asthma and in children in the control group without respiratory pathology using a respiratory sound recorder. Materials and methods. External respiration function was assessed using computer bronchophonography using a respiratory sound recorder; 215 practically healthy children from 1 to 18 years old, who formed the control group, were examined. The main group of those examined included children with moderate (n=80) and severe bronchial asthma (n=40), of which (n=54) patients were examined in exacerbation. Results. In all patients with asthma in the main group with exacerbation, the acoustic component of work of breathing (ACWP) was significantly higher than in the control group. Differences were detected in the low-frequency P1, mid-frequency P2 and high-frequency range P3 (p0.05). When comparing ACRD in patients with asthma with exacerbation and remission, a statistically significant difference was revealed in all frequency ranges (p0.005). When analyzing the duration of inhalation and exhalation in healthy children of different ages, no statistically significant difference was revealed. In patients with exacerbated asthma, inhalation and exhalation were significantly longer than in a healthy child (p0.005). Conclusion. Our study shows that a respiratory sound recorder can be effectively used to diagnose bronchial obstruction disorders in children of different ages.
- 10 May 2024
- Published by The National Academy of Pediatric Science and Innovation in Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)
- Vol. 69 (2) , 78-85
Microcirculation indicators in children with bronchial asthma
In pediatric practice, non-invasive methods are relevant that allow one to study the state of blood microflow. One such method is laser Doppler flowmetry.Purpose. To evaluate the state of blood microcirculation in children with bronchial asthma by laser Doppler flowmetry during periods of exacerbation and remission of the disease.Material and methods. 40 healthy children aged 9–17 years (13.7 ± 1.8) were examined, which made up the control group. The main group of the examined were children with moderate and severe bronchial asthma (n=60) during the period of exacerbation (n=29) and remission (n=31) of similar age. To diagnose the general condition, the microcirculation of blood used a system of portable blood microcirculation LAZMA PF. From the LAZMA PF analyzers, a distributed system consisting of four devices was organized: two analyzers for simultaneous research on the 3rd finger of the hands and on the 1st toes. The record of indicators from 4 analyzers was carried out simultaneously in the position of the subject sitting for 10 minutes.Results. When studying the indicator of the microcirculatory-tissue system in children with bronchial asthma of moderate and severe severity who are in remission, we did not reveal significant differences from the indicators in healthy children. When assessing active regulation mechanisms affecting the state of microcirculation, a reliable decrease in the amplitudes of vibrations of endothelial regulation in patients with bronchial asthma compared to healthy children (p<0.05) was revealed. When comparing passive oscillations of blood flow in patients with bronchial asthma, a significant decrease in the amplitudes of oscillations in the cardiac range was revealed in comparison with the control group (p<0.05). Scope of results: medicine, pediatrics, therapy, pulmonology, allergology.Conclusion. The laser Doppler flowmetry can be used as an additional criterion for the diagnosis and control of the therapy of bronchial asthma in children.
- 10 May 2024
- Published by The National Academy of Pediatric Science and Innovation in Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)
- Vol. 69 (2) , 78-85
Microcirculation indicators in children with bronchial asthma
In pediatric practice, non-invasive methods are relevant that allow one to study the state of blood microflow. One such method is laser Doppler flowmetry.Purpose. To evaluate the state of blood microcirculation in children with bronchial asthma by laser Doppler flowmetry during periods of exacerbation and remission of the disease.Material and methods. 40 healthy children aged 9–17 years (13.7 ± 1.8) were examined, which made up the control group. The main group of the examined were children with moderate and severe bronchial asthma (n=60) during the period of exacerbation (n=29) and remission (n=31) of similar age. To diagnose the general condition, the microcirculation of blood used a system of portable blood microcirculation LAZMA PF. From the LAZMA PF analyzers, a distributed system consisting of four devices was organized: two analyzers for simultaneous research on the 3rd finger of the hands and on the 1st toes. The record of indicators from 4 analyzers was carried out simultaneously in the position of the subject sitting for 10 minutes.Results. When studying the indicator of the microcirculatory-tissue system in children with bronchial asthma of moderate and severe severity who are in remission, we did not reveal significant differences from the indicators in healthy children. When assessing active regulation mechanisms affecting the state of microcirculation, a reliable decrease in the amplitudes of vibrations of endothelial regulation in patients with bronchial asthma compared to healthy children (p<0.05) was revealed. When comparing passive oscillations of blood flow in patients with bronchial asthma, a significant decrease in the amplitudes of oscillations in the cardiac range was revealed in comparison with the control group (p<0.05). Scope of results: medicine, pediatrics, therapy, pulmonology, allergology.Conclusion. The laser Doppler flowmetry can be used as an additional criterion for the diagnosis and control of the therapy of bronchial asthma in children.
- Open Access
- 26 March 2024
- Published by LLC Global Media Technology in Archives of Pediatrics and Pediatric Surgery
- Vol. 2 (1) , 79-87
Study of the effectiveness and safety of a combination of a hypertonic solution and high molecular weight hyaluronic acid (Ingasalin® 3%) in the form of inhalation in the treatment of acute bronchitis against the background of acute respiratory infections in children 3-7 years old
Исследование эффективности и безопасности комбинации гипертонического раствора и высокомолекулярной гиалуроновой кислоты (Ингасалин® 3%) в виде ингаляции в терапии острого бронхита на фоне ОРИ у детей 3-7 лет
- 26 March 2024
- Published by LLC Global Media Technology in Archives of Pediatrics and Pediatric Surgery
- Vol. 2 (1) , 79-87
Open AccessStudy of the effectiveness and safety of a combination of a hypertonic solution and high molecular weight hyaluronic acid (Ingasalin® 3%) in the form of inhalation in the treatment of acute bronchitis against the background of acute respiratory infections in children 3-7 years old
Исследование эффективности и безопасности комбинации гипертонического раствора и высокомолекулярной гиалуроновой кислоты (Ингасалин® 3%) в виде ингаляции в терапии острого бронхита на фоне ОРИ у детей 3-7 лет
- Open Access
- 31 October 2023
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 17,p. 62-67
Symptomatic treatment of cough in children
Cough is one of the most common symptoms in paediatric practice. Cough nature, duration, intensity, frequency, time and cause of occurrence should be considered in the differential diagnosis of its causes. Sputum evacuation disorders and changes in its rheological properties are indications for the prescription of mucoactive drugs. Despite the fact that the drugs included in this group have different mechanisms of action, all of them restore mucociliary clearance and lead to effective evacuation of secretions from the respiratory tract. Herbal medicinal products can be used along with classic mucoactive drugs (mucolytics, mucopegulators and mucokinetics). Ivy leaves are an example of a well-known and meticulously researched source of phytopharmaceutical products, they are included in the ESCOP monograph and entered into the positive list of the German Commission E. The efficacy and safety of ivy leaf products have been demonstrated in various controlled clinical studies. The authors presented a review of published clinical studies and non-interventional studies involving a total of 65,383 patients suffering from both acute and chronic respiratory diseases. The studies demonstrated the efficacy of ivy leaf extract preparations as achievement of a higher level of bronchodilation and surfactant production, which led to bronchospasmolytic, secretolytic, expectorant and, in turn, antitussive action. Herbal medicinal products are now actively used in the treatment of new coronavirus infection. Hedelix is one of the ivy leaf extract pharmaceutical preparations approved for use in children over the age of two years.
- 31 October 2023
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 17,p. 62-67
Open AccessSymptomatic treatment of cough in children
Cough is one of the most common symptoms in paediatric practice. Cough nature, duration, intensity, frequency, time and cause of occurrence should be considered in the differential diagnosis of its causes. Sputum evacuation disorders and changes in its rheological properties are indications for the prescription of mucoactive drugs. Despite the fact that the drugs included in this group have different mechanisms of action, all of them restore mucociliary clearance and lead to effective evacuation of secretions from the respiratory tract. Herbal medicinal products can be used along with classic mucoactive drugs (mucolytics, mucopegulators and mucokinetics). Ivy leaves are an example of a well-known and meticulously researched source of phytopharmaceutical products, they are included in the ESCOP monograph and entered into the positive list of the German Commission E. The efficacy and safety of ivy leaf products have been demonstrated in various controlled clinical studies. The authors presented a review of published clinical studies and non-interventional studies involving a total of 65,383 patients suffering from both acute and chronic respiratory diseases. The studies demonstrated the efficacy of ivy leaf extract preparations as achievement of a higher level of bronchodilation and surfactant production, which led to bronchospasmolytic, secretolytic, expectorant and, in turn, antitussive action. Herbal medicinal products are now actively used in the treatment of new coronavirus infection. Hedelix is one of the ivy leaf extract pharmaceutical preparations approved for use in children over the age of two years.
- Open Access
- 15 November 2022
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 19,p. 122-129
Long-standing foreign body in the right bronchus of a 7-year-old girl
Foreign body aspiration (FB) is one of the leading causes of death from accidents among preschool children. Every year, up to 8% of children worldwide die as a result of foreign body aspiration. In developed countries, the mortality rate is lower, but the problem remains no less urgent due to the high attendance at emergency departments. Longstanding foreign bodies deserve special attention. The absence of an aspiration episode in the anamnesis of the disease, nonspecific respiratory symptoms, “X-ray negative” foreign bodies, as well as organic FB can complicate the diagnostic search. The article presents data from domestic and foreign literature on epidemiology, risk factors, clinical features, as well as modern approaches to the diagnosis and treatment of foreign body aspiration. The authors present their own clinical observation of a long-standing foreign body in the bronchus in a 7-year-old child. Prolonged cough and repeated episodes of bronchial obstruction for 4 years were regarded as the onset of bronchial asthma. The lack of effect from ongoing bronchodilator and anti-inflammatory therapy with high doses of inhaled glucocorticosteroids dictated the need to expand the diagnostic search, and therefore the child was sent for examination in a hospital to the pulmonology department of the Children’s Clinical Hospital I.M. Sechenov. During endoscopic examination, a metal spiral spring (7 mm in size) was found in the child and simultaneously removed, which was presumably within 4 years in the right bronchus. Over the next 6 months, bronchial obstruction did not recur, there were no complaints.
- 15 November 2022
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 19,p. 122-129
Open AccessLong-standing foreign body in the right bronchus of a 7-year-old girl
Foreign body aspiration (FB) is one of the leading causes of death from accidents among preschool children. Every year, up to 8% of children worldwide die as a result of foreign body aspiration. In developed countries, the mortality rate is lower, but the problem remains no less urgent due to the high attendance at emergency departments. Longstanding foreign bodies deserve special attention. The absence of an aspiration episode in the anamnesis of the disease, nonspecific respiratory symptoms, “X-ray negative” foreign bodies, as well as organic FB can complicate the diagnostic search. The article presents data from domestic and foreign literature on epidemiology, risk factors, clinical features, as well as modern approaches to the diagnosis and treatment of foreign body aspiration. The authors present their own clinical observation of a long-standing foreign body in the bronchus in a 7-year-old child. Prolonged cough and repeated episodes of bronchial obstruction for 4 years were regarded as the onset of bronchial asthma. The lack of effect from ongoing bronchodilator and anti-inflammatory therapy with high doses of inhaled glucocorticosteroids dictated the need to expand the diagnostic search, and therefore the child was sent for examination in a hospital to the pulmonology department of the Children’s Clinical Hospital I.M. Sechenov. During endoscopic examination, a metal spiral spring (7 mm in size) was found in the child and simultaneously removed, which was presumably within 4 years in the right bronchus. Over the next 6 months, bronchial obstruction did not recur, there were no complaints.
- Open Access
- 26 February 2022
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 1,p. 58-63
The role of herbal medicines in treating cough in children
The physiological role of cough is to restore mucociliary clearance in the respiratory tract. However, if there are inflammatory changes against the background of a respiratory infection, cough may be non-productive and impair the patient’s quality of life. For a rational choice of drug, the true cause of cough should be determined on the basis of history, physical examination and, if necessary, additional instrumental/laboratory investigations. Modern phytopharmaceuticals are considered effective and safe for cough relief. Herbal medicines contain biologically active substances, which are incorporated into the metabolic processes of the body in a more natural way, in contrast to synthetic analogues. The article focuses on the effectiveness of an ivy leaf extract, which has a complex composition: it contains saponins, flavonoids, glycosides, as well as components of essential oils. Due to its composition, it has several effects: expectorant due to its secretolytic and mucolytic action, and antispasmodic based on the increased sensitivity of β2-adrenoreceptor cells of bronchial smooth muscle cells to endogenous and exogenous stimulation, on reducing intracellular calcium levels and bronchial relaxation. The efficacy of ivy leaf extract has been shown in a total of more than 20 clinical trials, mainly in children suffering from upper respiratory tract infections. Cough treatment aims at changing the rheological properties of the secretion and increasing the effectiveness of the cough. The good compatibility of herbal medicines with other drugs, including antibiotics, allows their use not only as monotherapeutic agents, but also in combination therapy for the treatment of cough in children.
- 26 February 2022
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 1,p. 58-63
Open AccessThe role of herbal medicines in treating cough in children
The physiological role of cough is to restore mucociliary clearance in the respiratory tract. However, if there are inflammatory changes against the background of a respiratory infection, cough may be non-productive and impair the patient’s quality of life. For a rational choice of drug, the true cause of cough should be determined on the basis of history, physical examination and, if necessary, additional instrumental/laboratory investigations. Modern phytopharmaceuticals are considered effective and safe for cough relief. Herbal medicines contain biologically active substances, which are incorporated into the metabolic processes of the body in a more natural way, in contrast to synthetic analogues. The article focuses on the effectiveness of an ivy leaf extract, which has a complex composition: it contains saponins, flavonoids, glycosides, as well as components of essential oils. Due to its composition, it has several effects: expectorant due to its secretolytic and mucolytic action, and antispasmodic based on the increased sensitivity of β2-adrenoreceptor cells of bronchial smooth muscle cells to endogenous and exogenous stimulation, on reducing intracellular calcium levels and bronchial relaxation. The efficacy of ivy leaf extract has been shown in a total of more than 20 clinical trials, mainly in children suffering from upper respiratory tract infections. Cough treatment aims at changing the rheological properties of the secretion and increasing the effectiveness of the cough. The good compatibility of herbal medicines with other drugs, including antibiotics, allows their use not only as monotherapeutic agents, but also in combination therapy for the treatment of cough in children.
- Open Access
- 1 November 2021
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 17,p. 78-84
Application of hypertonic saline in children with acute bronchitis
Introduction. Cough is the most common manifestation of respiratory infections of the upper and lower respiratory tract and indicates impaired mucociliary clearance. The cause of cough must be determined to choose the management tactics for children with cough. The most commonly used mucoactive drugs liquefy sputum as a result of a direct action of the components on the tracheobronchial secretion and/or mucosa of the respiratory tract. Given the mucoactive effect of hypertonic salines, we conducted an open clinical study of the effectiveness of 3% hypertonic saline with hyaluronic acid in acute bronchitis in children.Aim of the study. To evaluate the clinical effect of 3% hypertonic saline with hyaluronic acid in acute bronchitis in children.Materials and methods. Clinical efficacy and safety of 3% hypertonic saline with hyaluronic acid in 50 patients aged 3 to 12 years old with acute bronchitis were evaluated in the dynamics on the 1st, 3rd, 7th days of treatment with the score assessment of symptoms (cough, stuffy nose, auscultation data) and an indication of adverse events (if any).Results. Improvement of condition was noted in most patients by the 3rd day of therapy (mean score 1.88 ± 0.3), temperature normalized in all patients, manifestations of rhinitis decreased. By the 5th day of treatment, the intensity of cough did not exceed 1 point in all patients (0.7 ± 0.14 points). According to the patient’s diary data, by the 7th day of treatment 74% of the children had no cough. On the 7th day of treatment, some children had a rare residual cough (0.36 ± 0.06 points), minor rhinitis (0.16 ± 0.1 points). No rales were heard in the lungs in all patients, rigid breathing was heard in 11 patients (mean score 0.22 ± 0.05).Conclusions. The conducted study demonstrated that 3% hypertonic saline with hyaluronic acid is an effective drug in the treatment of cough in acute bronchitis in children.
- 1 November 2021
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 17,p. 78-84
Open AccessApplication of hypertonic saline in children with acute bronchitis
Introduction. Cough is the most common manifestation of respiratory infections of the upper and lower respiratory tract and indicates impaired mucociliary clearance. The cause of cough must be determined to choose the management tactics for children with cough. The most commonly used mucoactive drugs liquefy sputum as a result of a direct action of the components on the tracheobronchial secretion and/or mucosa of the respiratory tract. Given the mucoactive effect of hypertonic salines, we conducted an open clinical study of the effectiveness of 3% hypertonic saline with hyaluronic acid in acute bronchitis in children.Aim of the study. To evaluate the clinical effect of 3% hypertonic saline with hyaluronic acid in acute bronchitis in children.Materials and methods. Clinical efficacy and safety of 3% hypertonic saline with hyaluronic acid in 50 patients aged 3 to 12 years old with acute bronchitis were evaluated in the dynamics on the 1st, 3rd, 7th days of treatment with the score assessment of symptoms (cough, stuffy nose, auscultation data) and an indication of adverse events (if any).Results. Improvement of condition was noted in most patients by the 3rd day of therapy (mean score 1.88 ± 0.3), temperature normalized in all patients, manifestations of rhinitis decreased. By the 5th day of treatment, the intensity of cough did not exceed 1 point in all patients (0.7 ± 0.14 points). According to the patient’s diary data, by the 7th day of treatment 74% of the children had no cough. On the 7th day of treatment, some children had a rare residual cough (0.36 ± 0.06 points), minor rhinitis (0.16 ± 0.1 points). No rales were heard in the lungs in all patients, rigid breathing was heard in 11 patients (mean score 0.22 ± 0.05).Conclusions. The conducted study demonstrated that 3% hypertonic saline with hyaluronic acid is an effective drug in the treatment of cough in acute bronchitis in children.
- 1 January 2021
- Published by Geotar-Media Publishing Group in Immunologiya
- Vol. 42 (3)
COVID-19 in children with bronchial asthma: clinical manifestations, course options, approaches to therapy
COVID-19 у детей с бронхиальной астмой: клинические проявления, варианты течения, подходы к терапии
- 1 January 2021
- Published by Geotar-Media Publishing Group in Immunologiya
- Vol. 42 (3)
COVID-19 in children with bronchial asthma: clinical manifestations, course options, approaches to therapy
COVID-19 у детей с бронхиальной астмой: клинические проявления, варианты течения, подходы к терапии